Phase III Randomized Study of Cisplatin-Containing Chemotherapy With Versus Without Bevacizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (Bevacizumab Provided)
ECOG 1305  (MBMC Contact: Chris Sanders 314-996-5802)  Click For Consent ***      Click for Protocol

Phase III Randomized Study of Adjuvant Intensity-Modulated Radiotherapy With Versus Without Cetuximab in Patients With Locally Advanced Resected Squamous Cell Carcinoma of the Head and Neck  (Cetuximab Provided) 
RTOG 0920  (MBMC Contact: Chris Sanders 314-996-5802)  Call Chris Sanders for Consent ***  (RTOG Credentialing Required for Affiliate Sites Prior to Patient Registration - See Protocol)

***Available through CTSU